We are live on ! Find out more
LJHT

Laurie J. Hall Trustee Portfolio holdings

AUM $322M
1-Year Est. Return 33.73%
This Fund
S&P 500
This Quarter Est. Return
-5.15%
1 Year Est. Return
+33.73%
3 Year Est. Return
+96.04%
5 Year Est. Return
+120.73%
10 Year Est. Return
AUM
$203M
AUM Growth
-$11M
Cap. Flow
+$1.76M
Cap. Flow %
0.87%
Top 10 Hldgs %
34.78%
Holding
328
New
7
Increased
24
Reduced
122
Closed
7

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$1.31M
2
PYPL icon
PayPal
PYPL
+$1.24M
3
NTR icon
Nutrien
NTR
+$211K
4
CDK
CDK Global, Inc.
CDK
+$207K
5
AMD icon
Advanced Micro Devices
AMD
+$130K

Sector Composition

Rank Sector Weight
1 Healthcare 27.28%
2 Technology 24.66%
3 Industrials 13.23%
4 Consumer Staples 9.47%
5 Communication Services 6.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FARO
276
DELISTED
Faro Technologies
FARO
$5K ﹤0.01%
190
-95
-33% -$3.1K
PPLI
277
People Inc
PPLI
$3.1B
$5K ﹤0.01%
116
-61
-34% -$3.43K
PRTA icon
278
Prothena Corp
PRTA
$450M
$5K ﹤0.01%
80
-30
-27% -$948
PTCT icon
279
PTC Therapeutics
PTCT
$6.12B
$5K ﹤0.01%
105
-40
-28% -$1.96K
UCTT
280
Ultra Clean Holdings
UCTT
$3.95B
$5K ﹤0.01%
210
-90
-30% -$2.75K
ITCI
281
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$5K ﹤0.01%
115
-55
-32% -$2.87K
EGIO
282
DELISTED
Edgio, Inc. Common Stock
EGIO
$5K ﹤0.01%
48
+15
+45% +$1.77K
CARS icon
283
Cars.com
CARS
$660M
$4K ﹤0.01%
316
MTCH icon
284
Match Group
MTCH
$8.55B
$4K ﹤0.01%
81
-45
-36% -$2.83K
NOK icon
285
Nokia
NOK
$52.3B
$4K ﹤0.01%
1,000
SAGE
286
DELISTED
Sage Therapeutics
SAGE
$4K ﹤0.01%
90
-40
-31% -$1.55K
TVRD
287
Tvardi Therapeutics
TVRD
$23.4M
$4K ﹤0.01%
11
-5
-31% -$1.81K
CCL icon
288
Carnival Corporation Ltd
CCL
$39.7B
$3K ﹤0.01%
400
CRNC icon
289
Cerence
CRNC
$413M
$3K ﹤0.01%
190
-90
-32% -$2.02K
FANG icon
290
Diamondback Energy
FANG
$52.7B
$3K ﹤0.01%
26
-15
-37% -$1.87K
HP icon
291
Helmerich & Payne
HP
$3.71B
$3K ﹤0.01%
85
-45
-35% -$1.89K
LXRX icon
292
Lexicon Pharmaceuticals
LXRX
$1.1B
$3K ﹤0.01%
1,140
-510
-31% -$1.41K
NET icon
293
Cloudflare
NET
$107B
$3K ﹤0.01%
50
IMGN
294
DELISTED
Immunogen Inc
IMGN
$3K ﹤0.01%
675
-305
-31% -$1.61K
AMRS
295
DELISTED
Amyris Inc.
AMRS
$3K ﹤0.01%
1,095
-495
-31% -$1.35K
RARE icon
296
Ultragenyx Pharmaceutical
RARE
$2.55B
$2K ﹤0.01%
60
-30
-33% -$1.54K
SSP icon
297
E.W. Scripps
SSP
$304M
$2K ﹤0.01%
210
-90
-30% -$1.27K
UFI icon
298
UNIFI
UFI
$134M
$2K ﹤0.01%
205
-105
-34% -$1.31K
VTR icon
299
Ventas
VTR
$47.9B
$2K ﹤0.01%
50
ICPT
300
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$2K ﹤0.01%
130
+40
+44% +$644

Similar funds

Laurie J. Hall Trustee's Q3 2022 Portfolio in Review

As of Q3 2022, Laurie J. Hall Trustee held 328 positions worth $203M, down 5.1% from $214M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Trading was light in Q3 2022: portfolio turnover was 4.3%. Laurie J. Hall Trustee opened 7 new positions and exited 7, leaving the 328-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 28% a quarter earlier, followed by Technology and Industrials.

  • Laurie J. Hall Trustee's largest Q3 2022 buy was Vanguard FTSE All-World ex-US ETF: 6,626 shares worth $294K.
  • Laurie J. Hall Trustee added most to Unilever in Q3 2022, an estimated $1.75M increase.
  • Laurie J. Hall Trustee's biggest Q3 2022 reduction was Medtronic, cutting an estimated $1.31M.
  • Laurie J. Hall Trustee fully exited Nutrien in Q3 2022, selling an estimated $211K.
  • Laurie J. Hall Trustee's ten largest holdings make up 35% of its $203M portfolio in Q3 2022.
  • Laurie J. Hall Trustee opened 7 new positions and closed 7 in Q3 2022.
  • Laurie J. Hall Trustee's portfolio value fell 5.1% quarter-over-quarter to $203M.

Based on Laurie J. Hall Trustee's 13F filing for Q3 2022, filed 11 Oct 2022.